相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
Hanna Bandos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
Hanna Bandos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study
Susana Pereira et al.
SUPPORTIVE CARE IN CANCER (2016)
A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis
Filipa Fontes et al.
BREAST (2016)
Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) -Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline
Neelima Denduluri et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Docetaxel-induced neuropathy: A pharmacogenetic case-control study of 150 women with early-stage breast cancer
Lise Eckhoff et al.
ACTA ONCOLOGICA (2015)
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2015)
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors
L. Eckhoff et al.
EUROPEAN JOURNAL OF CANCER (2015)
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression
U. Nitz et al.
ANNALS OF ONCOLOGY (2014)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer
L. Eckhoff et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Chemotherapy-Induced Peripheral Neurotoxicity: A Critical Analysis
Susanna B. Park et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Reliability of adverse symptom event reporting by clinicians
Thomas M. Atkinson et al.
QUALITY OF LIFE RESEARCH (2012)
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
Dawn L. Hershman et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
Kojiro Shimozuma et al.
SUPPORTIVE CARE IN CANCER (2009)
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Sherry Wolf et al.
EUROPEAN JOURNAL OF CANCER (2008)
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
Keun Seok Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: Final results of the ARCOSEIN trial
Alain Toledano et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy
FH Hausheer et al.
SEMINARS IN ONCOLOGY (2006)
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
TJ Postma et al.
EUROPEAN JOURNAL OF CANCER (2005)
Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy
EA Calhoun et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2003)
Toxic neuropathy in patients with pre-existing neuropathy
V Chaudhry et al.
NEUROLOGY (2003)
Understanding the utility of adjuvant systemic therapy for primary breast cancer
CL Loprinzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
